Psoriatic Arthritis Therapeutics Market by Drug Class (Interleukin Inhibitors, TNF Inhibitors, PDE4 Inhibitors, and Others), by Disease Type (Asymmetric Psoriatic Arthritis, Symmetric Psoriatic Arthritis, Distal Interphalangeal Predominant (DIP) Psoriatic Arthritis, Spondylitis, and Arthritis Mutilans), and by Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025
Published Date: 01-Jul-2019Pharmaceutical
Category: Report Format : PDF
Report Code: ZMR-4271
Status : Published
psoriatic arthritis treatments will reach USD 16.71 billion, rising 11.2% annually. Rising psoriasis and arthritis incidence fuel the global psoriatic arthritis therapy sector.